![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Tempest Therpeutics Inc | NASDAQ:TPST | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0192 | -0.86% | 2.2008 | 2.20 | 2.21 | 2.255 | 2.1904 | 2.22 | 170,512 | 18:11:42 |
☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
45-1472564 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
7000 Shoreline Court, Suite 275 South San Francisco, California |
94080 | |
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on which Registered | ||
Common Stock, $0.001 par value |
TPST |
The Nasdaq Stock Market |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
☐ | Emerging growth company | ☐ |
Auditor Firm ID: 42 Auditor Firm ID: 34 |
Auditor Name: Ernst & Young LLP Auditor Name: Deloitte & Touche LLP |
Auditor Location: Grand Rapids, Michigan Auditor Location: |
ITEM 15. |
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES |
+ | Indicates management contract or compensatory plan. |
^ | These certifications were furnished solely to accompany the Annual Report pursuant to 18 U.S.C. Section 1350, and were not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |
TEMPEST THERAPEUTICS, INC. | ||
By: |
/s/ Stephen Brady | |
Stephen Brady | ||
Chief Executive Officer (Principal Executive Officer) |
1 Year Tempest Therpeutics Chart |
1 Month Tempest Therpeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions